Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy

Part of paid clinical trials in Fort Wayne, Indiana.

Sponsor
Joseph McCollom
Study ID
NCT05014399
Status
Recruiting
Apply to this trial

Conditions

  • Chemo Fog
  • Chemo-brain
  • Chemotherapy Effect
  • Cognitive Change
  • Cognitive Decline
  • Cognitive Dysfunction
  • Cognitive Impairment
  • Neoplasm, Colorectal

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this research study is to see how the brain changes in patients receiving chemotherapy (cytotoxic drug) treatment for colon or rectal cancer at Parkview Cancer Institute. This information will be used to identify helpful tests to diagnose individuals at risk for developing difficulties with thinking and memory due to their cancer treatments.

Key Dates

Start date
Sep 20, 2021
Status verified
Jun 2025
Primary completion
Oct 31, 2026
Completion
Oct 31, 2031

Study Design

Enrollment
60 participants (estimated)

Primary Outcome Measure

Survey [ Time Frame: 7 Years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Parkview Cancer InstituteFort WayneIndiana46845
Dr Joseph McCollom, DO
[email protected]
260-266-7100

Find similar trials in Fort Wayne, IN

By research site
Parkview Cancer Institute· Fort Wayne, IN

Related Studies